Antimicrobials and the Risk of Torsades de Pointes: The Contribution from Data Mining of the US FDA Adverse Event Reporting System

By Poluzzi Elisabetta  

Drug Safety, Vol. 33, Iss. 4, 2010-04 ,pp. : 303-314

Adis International

Access to resources Recommend Favorite

An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database

By Wang Hsin-wei  

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1117-1133

Adis International

Access to resources Recommend Favorite

Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature

By Raisch Dennis W   Garg Vishvas   Arabyat Rasha   Shen Xian   Edwards Beatrice J   Miller Frank H   McKoy June M   Nardone Beatrice   West Dennis P  

Expert Opinion on Drug Safety, Vol. 13, Iss. 1, 2014-01 ,pp. : 15-23

Informa Healthcare

Access to resources Recommend Favorite

Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database: A Disproportionality Analysis

By Shamloo Behrooz K.  

Drug Safety, Vol. 35, Iss. 6, 2012-06 ,pp. : 507-518

Adis International

Access to resources Recommend Favorite

Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database

By Motola Domenico  

Drug Safety, Vol. 35, Iss. 4, 2012-04 ,pp. : 315-323

Adis International

Access to resources Recommend Favorite